Recent News

• 11.06.2026 - Integra LifeSciences to Present at the 2026 UBS Global Healthcare Conference
• 10.30.2026 - Integra LifeSciences to Highlight Hands-On Education and Neurosurgery Innovation at CNS 2026 Annual Meeting
• 10.21.2026 - Integra LifeSciences Reports Third Quarter 2026 Financial Results
• 10.19.2026 - Integra Announces Completion of Refinancing Transactions
• 10.16.2026 - Integra LifeSciences to Highlight ENT and Instruments Portfolios and Sponsor New Clinical Research Presentations at AAO-HNSF 2026 Annual Meeting
• 10.09.2026 - Integra Announces Pricing of Senior Secured Notes
• 10.06.2026 - Integra LifeSciences to Host Third Quarter 2026 Financial Results Conference Call on October 21, 2026
• 10.02.2026 - Integra LifeSciences Announces Preliminary Third Quarter Results and Updates Full-Year 2026 Guidance
• 10.02.2026 - Integra LifeSciences Announces Launch of $600 Million Senior Secured Term Loan B
• 09.29.2026 - Integra LifeSciences Announces 100th Patient Enrolled in AERA® Pediatric Registry

Recent Filings

• 10.23.2026 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 10.21.2026 - EX-99.1 EX-99.1
• 10.21.2026 - 8-K Current report
• 10.19.2026 - 8-K Current report
• 10.19.2026 - EX-99.1 EX-99.1
• 10.13.2026 - 3 Initial statement of beneficial ownership of securities
• 10.09.2026 - 8-K Current report
• 10.09.2026 - EX-99.1 EX-99.1
• 10.02.2026 - 8-K Current report
• 10.02.2026 - EX-99.1 EX-99.1